Notice of Results

RNS Number : 8457P

e-Therapeutics plc

05 September 2017

 

E-THERAPEUTICS PLC

("e-therapeutics" or the "Company")

Notification of Half Year Results Date

Oxford, UK - 5 September 2017 - e-therapeutics plc (AIM: ETX), a company using Network-Driven Drug Discovery (NDD) to create new and better drugs, will announce its half year results for the six months ended 31 July 2017 on Tuesday, 26 September 2017.

-Ends-

For more information, please contact:

e-therapeutics plc Ray Barlow, Chief Executive Officer Steve Medlicott, Finance Director Tel: [phone] www.etherapeutics.co.uk  Numis Securities Limited Michael Meade/Freddie Barnfield (Corporate Finance) James Black (Corporate Broking) Tel: [phone] www.numis.com Instinctif Partners Melanie Toyne Sewell/Alex Shaw Tel: [phone] Email: [e-mail]

About e-therapeutics plc

We are an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology.  

Our novel methodology and our Discovery Engine allow us to discover new and better drugs in a more efficient and effective way.

e-therapeutics is headquartered in Oxford. For more information about the Company please visit www.etherapeutics.co.uk 

 

END

 

 

NORVELBBDKFZBBB